Clinical Trial Update: Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?

View source ↗

Summary

This clinical trial update describes research on assessing residual VHL function in tumors to predict the individual course of von Hippel-Lindau disease. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Hippel-lindau Disease

Snippet

Sponsor: Marie Luise Bisgaard, MD | Conditions: Von Hippel-Lindaus Disease | Status: UNKNOWN